Related Experiment Videos
Short- and long-term neurohormonal activation following acute myocardial infarction
A Sigurdsson1, P Held, K Swedberg
1Department of Medicine, Ostra Hospital, Göteborg, Sweden.
Insights
Sustained neurohormonal activation after myocardial infarction is linked to heart failure and infarct size. Even without heart failure, elevated neurohormones correlate with myocardial damage magnitude.
Area of Science:
- Cardiology
- Endocrinology
- Physiology
Background:
- Neurohormonal activation is a key factor in myocardial infarction (MI) pathophysiology.
- Atrial natriuretic peptide (ANP), angiotensin II, aldosterone, and catecholamines play significant roles in cardiovascular regulation.
- Understanding the temporal dynamics and correlates of neurohormonal changes post-MI is crucial for patient management.
Purpose of the Study:
- To investigate plasma levels of key neurohormones in patients following acute myocardial infarction.
- To determine the relationship between neurohormonal activation, heart failure development, and infarct size.
- To assess the utility of head-up tilt testing in detecting neurohormonal activation.
Main Methods:
- Longitudinal study of 55 patients with acute myocardial infarction.
- Measurement of plasma ANP, angiotensin II, aldosterone, and catecholamines at baseline, 1 month, and 4-6 months post-MI.
- Assessment of neurohormonal responses during head-up tilt testing.
- Correlation analysis between hormone levels, infarct size, and clinical heart failure status.
Main Results:
- Hormone levels peaked within 24 hours post-MI, normalizing in patients without heart failure.
- In patients with heart failure, angiotensin II and norepinephrine remained elevated at 1 month, and ANP at 4-6 months.
- Head-up tilt revealed greater increases in angiotensin II and norepinephrine in patients with overt heart failure.
- Infarct size correlated positively with ANP, angiotensin II, and norepinephrine levels, even in patients without heart failure.
Conclusions:
- Sustained neurohormonal activation post-MI primarily occurs in patients with clinical heart failure.
- The magnitude of myocardial damage is a significant determinant of neurohormonal activation, irrespective of heart failure presence.
- Head-up tilt testing may serve as an adjunctive method for detecting neurohormonal activation.
Abstract:
Plasma levels of atrial natriuretic peptide (ANP), angiotensin II, aldosterone, and catecholamines were followed for 1 month and then for 4 to 6 months in 55 patients with acute myocardial infarction. Plasma hormones were highest within the first 24 hours after the onset of infarction but normalized during the first few days in patients without heart failure. In patients with symptoms of heart failure, angiotensin II and norepinephrine remained elevated for 1 month and ANP remained elevated for 4 to 6 months. During head-up tilt, angiotensin II and norepinephrine increased most in patients with overt heart failure. Among patients with a first myocardial infarction, a positive correlation was found between infarct size and ANP, angiotensin II, and norepinephrine on day 5 to 7 and between infarct size and angiotensin II during head-up tilt at 1 month, and between infarct size and ANP at 1 month. A similar relationship was found when only patients without heart failure were studied. It is concluded that sustained neurohormonal activation after myocardial infarction mainly occurs in patients with clinical heart failure but is related to the magnitude of myocardial damage, even in patients without heart failure. Measurement of neurohormones during head-up tilt may be an additive assessment for the detection of neurohormonal activation.